Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate to severe non-malignant pain and opioid induced constipation: a UK cost-utility analysis

William Dunlop, Reiner Uhl, Iftekhar Khan, Anna Taylor, Garry Barton

Research output: Contribution to journalArticle

42 Citations (Scopus)
Original languageEnglish
Pages (from-to)564-675
Number of pages112
JournalJournal of Medical Economics
Volume15
DOIs
Publication statusPublished - 2012

Cite this